RESEARCH: INFLUENZA
FOLDING PROJECT #12425 PROFILE

Miniproteins are being designed to fight the flu by blocking a viral protein called hemagglutinin. Researchers want to use computer simulations to understand how these miniproteins bind and unbind from hemagglutinin, which could help create even better flu treatments.

Note: This TLDR is a simplication and may not be 100% accurate.

Designed miniprotein therapeutics occupy the middle ground between small molecule drugs and monoclonal antibody treatments for infectious disease.

Hemagglutinin is a viral fusion protein that allows H1 influenza A (HA) to bind sialic acid on cell surfaces, as well as being involved in the post-endocytosis mechanism of cellular infection.; The Baker lab at University of Washington has developed de novo designed miniproteins that bind hemagglutinin, and developed ways to improve their binding through affinity maturation.

Many of the mutations seen in affinity-matured sequences are not directly in the binding interface, and it is unclear how these changes lead to higher affinity.

Understanding this mechanism may help us better computationally design better binders.

We aim to use molecular dynamics simulations to examine ab initio binding pathways for these miniprotein binders, and use enhanced sampling methods to study the unbinding reaction.

Pairing these methods together will provide a robust description of the complete binding reaction for this system.

---

Miniprotein

A small protein designed for therapeutic purposes.

Miniproteins are engineered proteins that are smaller than traditional antibodies. They can be used as drugs because they can bind to specific targets in the body, like viruses or diseased cells. Miniproteins have advantages over larger drugs, such as being easier to produce and deliver.

---

Monoclonal Antibody

A laboratory-produced antibody that can target specific proteins.

Monoclonal antibodies are laboratory-made versions of natural antibodies found in the immune system. They are designed to recognize and bind to specific targets, like cancer cells or viruses. This targeting ability allows them to be used as powerful drugs to treat a wide range of diseases.

---

Hemagglutinin

A viral protein that allows influenza viruses to bind to host cells.

Hemagglutinin (HA) is a key protein found on the surface of influenza viruses. It plays a crucial role in infection by binding to sialic acid receptors on the surfaces of cells lining the respiratory tract. This binding allows the virus to attach to and enter host cells, initiating the infection process.

---

H1 Influenza A

Subtype of influenza A virus.

H1N1 is a subtype of influenza A virus. It's known for causing seasonal flu epidemics and occasionally pandemics. The 'H1' refers to the hemagglutinin protein on the surface of the virus, while 'N1' refers to the neuraminidase protein, which helps the virus spread.

---

Affinity Maturation

The process of improving the binding affinity of a protein to its target.

Affinity maturation is a technique used in biotechnology to enhance the effectiveness of proteins like antibodies. It involves making small changes to the protein's structure through mutation and selection, gradually increasing its ability to bind tightly to its intended target.

---

Molecular Dynamics Simulations

Computer simulations that model the movement of atoms and molecules over time.

Molecular dynamics simulations are powerful computational tools used in biotechnology to study the behavior of molecules. They simulate the interactions between atoms and molecules, allowing researchers to understand how proteins fold, how drugs bind to their targets, and how biological systems function at a molecular level.

---

Enhanced Sampling Methods

Techniques used in molecular dynamics simulations to sample rare events.

Enhanced sampling methods are crucial for studying rare events in molecular dynamics simulations. These techniques overcome the limitations of traditional simulations by allowing researchers to explore a wider range of possible configurations and uncover transient or infrequent processes that are essential for understanding complex biological systems.